Search

everythinglearnresearchcommunity

for

Search:↓

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

Low dose valproate in epileptic children mainly causes weight gain and other non-life-threatening side effects.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Excessive selenium from supplements can be harmful.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

High doses of Tridax procumbens extract can be toxic, affecting liver and kidneys.

The conclusion is that a new method can measure caffeine and drugs in hair, finding caffeine abusers have 70 times more caffeine than normal, with a proposed cut-off value for abuse.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

A woman successfully sued for not being told about a medication's side effects, emphasizing doctors' duty to inform patients.

Some patients who had a severe drug reaction developed long-term hair loss.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Valproic acid can rarely cause fluid buildup around the lungs and heart.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The conclusion is that dermatologists need to improve prescription practices to reduce errors and drug interaction risks.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Power-enhancing drugs can cause mood swings, aggression, anxiety, and physical side effects, questioning their overall benefits.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Integrating biological networks improves drug repurposing and ADR prediction.

Wnt-activating drugs generally do not increase cancer risk.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

Aqueous dispersion resin is safe to inhale at levels below 30 mg/m³.